Oncotelic Therapeutics, Inc. OTLC OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score

22/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Oncotelic Therapeutics, Inc. (OTLC) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 20/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

22/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

25/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

护城河

46/100

→ Income

✗

成长

15/100

→ Income

—

收入

N/A

No coverage

估值概览 — OTLC

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.00

EV/EBITDA0.0

每股数据

EPS (TTM)$-0.01

每股账面价值$0.00

每股营收$0.00

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2015	$-0.54	$0.00	$-13.65M	-
2016	$-0.51	$0.00	$-13.65M	-
2017	$-0.52	$-100.00	$-13.81M	-
2018	$-0.07	$-100.00	$-2.74M	-
2019	$-0.12	$0.00	$-7.39M	-
2020	$-0.13	$1.74M	$-11.5M	-660.6%
2021	$-0.04	$0.00	$-11.39M	-
2022	$0.04	$0.00	$17.82M	-
2023	$-0.02	$70K	$-7.9M	-11290.1%
2024	$-0.01	$0.00	$-4.52B	-